WORLD NEUROSURGERY, cilt.142, 2020 (SCI-Expanded)
BACKGROUND: Dual antiplatelet therapy consisting of aspirin and clopidogrel is the standard of care for neuro-interventional stenting and flow diversion. Platelet function testing has been increasingly performed to identify patients with a hypo- or hyper-response to clopidogrel. Ticagrelor has been a popular alternative antiplatelet agent for such patients. We assessed the role of platelet function testing in patients receiving ticagrelor and undergoing stenting or flow diversion.